- Home
- EVN vs AMLX Comparison
EVN vs AMLX Comparison
Compare EVN & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVN
- AMLX
- Stock Information
- Founded
- EVN 1998
- AMLX 2014
- Country
- EVN United States
- AMLX United States
- Employees
- EVN N/A
- AMLX N/A
- Industry
- EVN Investment Bankers/Brokers/Service
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- EVN Finance
- AMLX Health Care
- Exchange
- EVN Nasdaq
- AMLX Nasdaq
- Market Cap
- EVN 410.0M
- AMLX 459.1M
- IPO Year
- EVN N/A
- AMLX 2022
- Fundamental
- Price
- EVN $10.44
- AMLX $4.49
- Analyst Decision
- EVN
- AMLX Buy
- Analyst Count
- EVN 0
- AMLX 5
- Target Price
- EVN N/A
- AMLX $9.60
- AVG Volume (30 Days)
- EVN 101.2K
- AMLX 1.0M
- Earning Date
- EVN 01-01-0001
- AMLX 05-08-2025
- Dividend Yield
- EVN 4.78%
- AMLX N/A
- EPS Growth
- EVN N/A
- AMLX N/A
- EPS
- EVN 0.34
- AMLX N/A
- Revenue
- EVN N/A
- AMLX N/A
- Revenue This Year
- EVN N/A
- AMLX N/A
- Revenue Next Year
- EVN N/A
- AMLX N/A
- P/E Ratio
- EVN $29.94
- AMLX N/A
- Revenue Growth
- EVN N/A
- AMLX N/A
- 52 Week Low
- EVN $8.64
- AMLX $1.58
- 52 Week High
- EVN $10.45
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- EVN 62.71
- AMLX 49.58
- Support Level
- EVN $10.32
- AMLX $4.41
- Resistance Level
- EVN $10.53
- AMLX $4.95
- Average True Range (ATR)
- EVN 0.12
- AMLX 0.42
- MACD
- EVN 0.05
- AMLX -0.10
- Stochastic Oscillator
- EVN 83.93
- AMLX 16.54
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.